Niveen Abotouk

Suggest Changes
  • Citations Per Year

Writes About:

Learn More
AIMS To assess the efficacy and toxicity of methotrexate-paclitaxel-epirubicin-carboplatin combination as second-line chemotherapy in patients with metastatic transitional cell carcinoma (TCC) of the(More)
  • 1